Selected article for: "development program and drug development"

Author: Van Norman, Gail A.
Title: Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies
  • Document date: 2018_6_25
  • ID: 58ta20fg_16
    Snippet: 2) the potential benefit must justify the potential risks of the treatment; and 3) providing the treatment must not compromise or interfere with the ongoing FDA drug development program, such as by critically depleting a limited supply of investigational drug that is also needed for an ongoing study or a future study that is in the planning stages (4)......
    Document: 2) the potential benefit must justify the potential risks of the treatment; and 3) providing the treatment must not compromise or interfere with the ongoing FDA drug development program, such as by critically depleting a limited supply of investigational drug that is also needed for an ongoing study or a future study that is in the planning stages (4).

    Search related documents:
    Co phrase search for related documents
    • drug development and investigational drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • drug development and ongoing study: 1, 2
    • drug development and potential benefit: 1
    • drug development and potential risk: 1, 2, 3, 4, 5, 6
    • drug development and treatment provide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • future study and limited supply: 1
    • future study and ongoing study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • future study and potential benefit: 1
    • future study and potential risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • future study and treatment provide: 1, 2, 3, 4
    • investigational drug and potential benefit: 1, 2
    • investigational drug and potential risk: 1
    • investigational drug and treatment provide: 1
    • limited supply and potential risk: 1, 2, 3, 4
    • limited supply and treatment provide: 1, 2
    • ongoing study and potential benefit: 1, 2, 3, 4
    • ongoing study and potential risk: 1, 2, 3, 4, 5, 6, 7
    • ongoing study and treatment provide: 1, 2, 3, 4, 5, 6, 7
    • planning stage and treatment provide: 1